{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:08:05Z","timestamp":1791479285079,"version":"4.3.4"},"reference-count":80,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["16-15-00167"],"award-info":[{"award-number":["16-15-00167"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Arthritis is a widespread inflammatory disease associated with progressive articular surface degradation, ongoing pain, and hyperalgesia causing the development of functional limitations and disability. TRPV1 channel is one of the high-potential targets for the treatment of inflammatory diseases. Polypeptide APHC3 from sea anemone Heteractis crispa is a mode-selective TRPV1 antagonist that causes mild hypothermia and shows significant anti-inflammatory and analgesic activity in different models of pain. We evaluated the anti-inflammatory properties of APHC3 in models of monosodium iodoacetate (MIA)-induced osteoarthritis and complete Freund\u2019s adjuvant (CFA)-induced rheumatoid monoarthritis in comparison with commonly used non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac, ibuprofen, and meloxicam. Subcutaneous administration of APHC3 (0.1 mg\/kg) significantly reversed joint swelling, disability, grip strength impairment, and thermal and mechanical hypersensitivity. The effect of APHC3 was equal to or better than that of reference NSAIDs. Protracted treatment with APHC3 decreased IL-1b concentration in synovial fluid, reduced inflammatory changes in joints, and prevented the progression of cartilage degradation. Therefore, polypeptide APHC3 has the potential to be an analgesic and anti-inflammatory substance for the alleviation of arthritis symptoms.<\/jats:p>","DOI":"10.3390\/md19010039","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T05:17:34Z","timestamp":1610947054000},"page":"39","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Anti-Inflammatory and Analgesic Effects of TRPV1 Polypeptide Modulator APHC3 in Models of Osteo- and Rheumatoid Arthritis"],"prefix":"10.3390","volume":"19","author":[{"given":"Yulia A.","family":"Logashina","sequence":"first","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16\/10, 117997 Moscow, Russia"},{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8, bld. 2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia A.","family":"Palikova","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Prospekt Nauki, 6, 142290 Pushchino, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor A.","family":"Palikov","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Prospekt Nauki, 6, 142290 Pushchino, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly A.","family":"Kazakov","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Prospekt Nauki, 6, 142290 Pushchino, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3734-8644","authenticated-orcid":false,"given":"Sviatlana V.","family":"Smolskaya","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8, bld. 2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Dyachenko","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Prospekt Nauki, 6, 142290 Pushchino, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda V.","family":"Tarasova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8, bld. 2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-0980","authenticated-orcid":false,"given":"Yaroslav A.","family":"Andreev","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16\/10, 117997 Moscow, Russia"},{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8, bld. 2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(00)04264-1","article-title":"Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism","volume":"357","author":"Aspden","year":"2001","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","article-title":"Emerging regulators of the inflammatory process in osteoarthritis","volume":"11","author":"Terkeltaub","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): Cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.biopha.2017.05.055","article-title":"Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of Rheumatoid Arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5152\/eurjrheum.2015.0028","article-title":"Hydroxychloroquine-induced agranulocytosis in a patient with long-term rheumatoid arthritis","volume":"3","author":"Sames","year":"2016","journal-title":"Eur. J. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.08.131","article-title":"Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis","volume":"223","author":"Schatz","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A Phase II Trial of Lutikizumab, an Anti\u2013Interleukin-1\u03b1\/\u03b2 Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","article-title":"A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis\u2014The HUMOR trial","volume":"26","author":"Aitken","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor \u03b1 monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2019.02.034","article-title":"Emerging therapeutic agents in osteoarthritis","volume":"165","author":"Alcaraz","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yexmp.2006.04.007","article-title":"Attenuation of experimental arthritis in TRPV1R knockout mice","volume":"81","author":"Barton","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09200-6","article-title":"TDAG8, TRPV1, and ASIC3 involved in establishing hyperalgesic priming in experimental rheumatoid arthritis","volume":"7","author":"Hsieh","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1136\/ard.2010.148122","article-title":"The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis","volume":"70","author":"Valdes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbrc.2007.05.178","article-title":"Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis","volume":"359","author":"Engler","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11010-008-9927-x","article-title":"Expression of ion channels of the TRP family in articular chondrocytes from osteoarthritic patients: Changes between native and in vitro propagated chondrocytes","volume":"321","author":"Gavenis","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbrc.2008.02.155","article-title":"TRPV1 mediates cell death in rat synovial fibroblasts through calcium entry-dependent ROS production and mitochondrial depolarization","volume":"369","author":"Hu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1744-8069-6-46","article-title":"Impact of central and peripheral TRPV1 and ROS levels on proinflammatory mediators and nociceptive behavior","volume":"6","author":"Westlund","year":"2010","journal-title":"Mol. Pain"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/157015906778019554","article-title":"Inflammatory Pain: The Cellular Basis of Heat Hyperalgesia","volume":"4","author":"Huang","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0167-0115(94)00095-F","article-title":"Capsaicin effects on substance P and CGRP in rat adjuvant arthritis","volume":"55","author":"Ahmed","year":"1995","journal-title":"Regul. Pept."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0024-3205(83)90060-7","article-title":"Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis","volume":"32","author":"Colpaert","year":"1983","journal-title":"Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00011-016-0954-x","article-title":"Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees","volume":"65","author":"Markovics","year":"2016","journal-title":"Inflamm. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/annrheumdis-2013-203413","article-title":"Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain","volume":"74","author":"Kelly","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/rheumatology\/ket352","article-title":"Participation of the TRPV1 receptor in the development of acute gout attacks","volume":"53","author":"Hoffmeister","year":"2014","journal-title":"Rheumatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"23914","DOI":"10.1074\/jbc.M800776200","article-title":"Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1)","volume":"283","author":"Andreev","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1134\/S1068162009060065","article-title":"New polypeptide components from the Heteractis crispa sea anemone with analgesic activity","volume":"35","author":"Kozlov","year":"2009","journal-title":"Russ. J. Bioorganic Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nikolaev, M.V., Dorofeeva, N.A., Komarova, M.S., Korolkova, Y.V., Andreev, Y.A., Mosharova, I.V., Grishin, E.V., Tikhonov, D.B., and Kozlov, S.A. (2017). TRPV1 activation power can switch an action mode for its polypeptide ligands. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177077"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1134\/S160767290901013X","article-title":"V Analgesic effect of a polypeptide inhibitor of the TRPV1 receptor in noxious heat pain models","volume":"424","author":"Andreev","year":"2009","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.3390\/md11125100","article-title":"Polypeptide modulators of TRPV1 produce analgesia without hyperthermia","volume":"11","author":"Andreev","year":"2013","journal-title":"Mar. Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1523\/JNEUROSCI.5150-09.2010","article-title":"Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia","volume":"30","author":"Garami","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/pr.109.001263","article-title":"The transient receptor potential vanilloid-1 channel in thermoregulation: A thermosensor it is not","volume":"61","author":"Romanovsky","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e13038","DOI":"10.1111\/apha.13038","article-title":"TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds\u2019 pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development","volume":"223","author":"Garami","year":"2018","journal-title":"Acta Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107474","DOI":"10.1016\/j.pharmthera.2020.107474","article-title":"Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis","volume":"208","author":"Garami","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08923973.2018.1434793","article-title":"Experimental animal models for rheumatoid arthritis","volume":"40","author":"Choudhary","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-1-61779-561-9_18","article-title":"The monosodium iodoacetate model of osteoarthritis pain in the rat","volume":"851","author":"Marker","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3899\/jrheum.080346","article-title":"The interleukin 1\u03b2 pathway in the pathogenesis of osteoarthritis","volume":"35","author":"Daheshia","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"kew301","DOI":"10.1093\/rheumatology\/kew301","article-title":"Transforming growth factor \u03b2 activated kinase 1: A potential therapeutic target for rheumatic diseases","volume":"56","author":"Fechtner","year":"2016","journal-title":"Rheumatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","article-title":"Pro-inflammatory cytokines: The link between obesity and osteoarthritis","volume":"44","author":"Wang","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/bjp.2008.351","article-title":"The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor","volume":"155","author":"Holzer","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1085\/jgp.200308906","article-title":"Ca2+\/Calmodulin Modulates TRPV1 Activation by Capsaicin","volume":"123","author":"Rosenbaum","year":"2004","journal-title":"J. Gen. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0896-6273(02)00802-4","article-title":"cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation","volume":"35","author":"Bhave","year":"2002","journal-title":"Neuron"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s004410051307","article-title":"Changes in fibre populations of the rat hairy skin following selective chemodenervation by capsaicin","volume":"296","author":"Dux","year":"1999","journal-title":"Cell Tissue Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejphar.2004.07.037","article-title":"The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology","volume":"500","author":"Nagy","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.4833-06.2007","article-title":"The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation","volume":"27","author":"Gavva","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125674","article-title":"Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade","volume":"323","author":"Gavva","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.pain.2012.01.022","article-title":"Afferent drive elicits ongoing pain in a model of advanced osteoarthritis","volume":"153","author":"Okun","year":"2012","journal-title":"Pain"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2015.02.050","article-title":"Using gait analysis to assess weight bearing in rats with Freund\u2019s complete adjuvant-induced monoarthritis to improve predictivity: Interfering with the cyclooxygenase and nerve growth factor pathways","volume":"756","author":"Berge","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2011.01.027","article-title":"Ongoing pain in the MIA model of osteoarthritis","volume":"493","author":"Liu","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuropharm.2017.07.029","article-title":"Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia","volume":"125","author":"Tejada","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/pmt.16.4","article-title":"Pain in rheumatoid arthritis: Models and mechanisms","volume":"6","author":"Bas","year":"2016","journal-title":"Pain Manag."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"ref_54","first-page":"1","article-title":"Osteoarthritis","volume":"2","author":"Barr","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neulet.2004.08.023","article-title":"The monosodium iodoacetate model of osteoarthritis: A model of chronic nociceptive pain in rats?","volume":"370","author":"Combe","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pain.2004.11.008","article-title":"Development and pharmacological characterization of a rat model of osteoarthritis pain","volume":"114","author":"Pomonis","year":"2005","journal-title":"Pain"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.1780400917","article-title":"Mono-iodoacetate-induced experimental osteoarthritis: A dose-response study of loss of mobility, morphology, and biochemistry","volume":"40","author":"Guingamp","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/01926230390241800","article-title":"Mono-Iodoacetate-Induced Histologic Changes in Subchondral Bone and Articular Cartilage of Rat Femorotibial Joints: AN Animal Model of Osteoarthritis","volume":"31","author":"Guzman","year":"2003","journal-title":"Toxicol. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pain.2004.08.004","article-title":"Pain related behaviour in two models of osteoarthritis in the rat knee","volume":"112","author":"Fernihough","year":"2004","journal-title":"Pain"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: Bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/archinte.160.19.2947","article-title":"Safety and efficacy of meloxicam in the treatment of osteoarthritis: A 12-week, double-blind, multiple-dose, placebo-controlled trial","volume":"160","author":"Yocum","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/35.suppl_1.4","article-title":"Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2","volume":"35","author":"Engelhardt","year":"1996","journal-title":"Rheumatology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"934","DOI":"10.12688\/f1000research.18831.1","article-title":"Il-1 in osteoarthritis: Time for a critical review of the literature","volume":"8","author":"Vincent","year":"2019","journal-title":"F1000Research"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/rheumatology\/keu281","article-title":"Influence of model and matrix on cytokine profile in rat and human","volume":"53","author":"Finn","year":"2014","journal-title":"Rheumatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3858\/emm.2011.43.10.062","article-title":"Grape seed proanthocyanidin extract ameliorates monosodium iodoacetate induced osteoarthritis","volume":"43","author":"Woo","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Galindo, T., Reyna, J., and Weyer, A. (2018). Evidence for Transient Receptor Potential (TRP) Channel Contribution to Arthritis Pain and Pathogenesis. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040105"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.12688\/f1000research.22115.1","article-title":"Recent advances in the treatment of osteoarthritis","volume":"9","author":"Muschter","year":"2020","journal-title":"F1000Research"},{"key":"ref_69","first-page":"101","article-title":"TRPA1 Channel as a Regulator of Neurogenic Inflammation and Pain: Structure, Function, Role in Pathophysiology, and Therapeutic Potential of Ligands","volume":"84","author":"Logashina","year":"2019","journal-title":"Biochemistry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ncomms1559","article-title":"TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol","volume":"2","author":"Andersson","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.pain.2013.08.002","article-title":"Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel","volume":"154","author":"Materazzi","year":"2013","journal-title":"Pain"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1097\/j.pain.0000000000000669","article-title":"Crotalphine desensitizes TRPA1 ion channels to alleviate inflammatory hyperalgesia","volume":"157","author":"Bressan","year":"2016","journal-title":"Pain"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1074\/jbc.M116.757369","article-title":"Peptide from Sea Anemone Metridium senile Affects Transient Receptor Potential Ankyrin-repeat 1 (TRPA1) Function and Produces Analgesic","volume":"292","author":"Logashina","year":"2017","journal-title":"Effect. J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Logashina, Y.A., Solstad, R.G., Mineev, K.S., Korolkova, Y.V., Mosharova, I.V., Dyachenko, I.A., Palikov, V.A., Palikova, Y.A., Murashev, A.N., and Arseniev, A.S. (2017). New Disulfide-Stabilized Fold Provides Sea Anemone Peptide to Exhibit Both Antimicrobial and TRPA1 Potentiating Properties. Toxins, 9.","DOI":"10.3390\/toxins9050154"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 patch","volume":"107","author":"Anand","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/art.24837","article-title":"Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients","volume":"61","author":"Gwilym","year":"2009","journal-title":"Arthritis Care Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.joca.2018.12.017","article-title":"Characterisation of peripheral and central components of the rat monoiodoacetate model of Osteoarthritis","volume":"27","author":"Lockwood","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pep.2017.12.011","article-title":"Pilot production of the recombinant peptide toxin of Heteractis crispa as a potential analgesic by intein-mediated technology","volume":"145","author":"Esipov","year":"2018","journal-title":"Protein Expr. Purif."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2019.04.011","article-title":"Comparison of the antinociceptive profiles of morphine and oxycodone in two models of inflammatory and osteoarthritic pain in rat","volume":"854","author":"Garcia","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0192623312438738","article-title":"International Harmonization of Toxicologic Pathology Nomenclature: An Overview and Review of Basic Principles","volume":"40","author":"Mann","year":"2012","journal-title":"Toxicol. Pathol."}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/19\/1\/39\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:12:11Z","timestamp":1760159531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/19\/1\/39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,17]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["md19010039"],"URL":"https:\/\/doi.org\/10.3390\/md19010039","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,17]]}}}